Unity Biotechnology Inc (UBX) — Long-term Investment Intensity
Unity Biotechnology Inc (UBX) has a Long-term Investment Intensity of 3.3% as of March 2024. Long-term investments of $1.95 Million represent 3.3% of total assets of $58.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Explore UBX cash generation efficiency to assess how effectively this company generates cash.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Unity Biotechnology Inc Long-term Investment Intensity (2017–2021)
This chart shows how Unity Biotechnology Inc's Long-term Investment Intensity has evolved across 4 annual periods from 2017 to 2021. As of March 2024, the intensity stands at 3.3%, reflecting long-term investments of $1.95 Million against total assets of $58.86 Million USD. Explore UBX operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Unity Biotechnology Inc (2017–2021)
The table below presents the year-by-year Long-term Investment Intensity for Unity Biotechnology Inc from 2017 to 2021, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see UBX company net worth.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 1.6% | $1.99 Million | $124.71 Million | ▼ -9.8 pp |
| 2020 | 11.4% | $17.87 Million | $156.32 Million | ▲ +9.4 pp |
| 2019 | 2.0% | $3.02 Million | $151.22 Million | ▼ -3.0 pp |
| 2017 | 5.0% | $5.12 Million | $102.02 Million | — |